Toggle Main Menu Toggle Search

Open Access padlockePrints

Digital health technologies to strengthen patient-centred outcome assessment in clinical trials in inflammatory arthritis

Lookup NU author(s): Professor Fai Ng

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

© 2024 Elsevier Ltd. Common to all inflammatory arthritides, namely rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, and juvenile idiopathic arthritis, is a potential for reduced mobility that manifests through joint pain, swelling, stiffness, and ultimately joint damage. Across these conditions, consensus has been reached on the need to capture outcomes related to mobility, such as functional capacity and physical activity, as core domains in randomised controlled trials. Existing endpoints within these core domains rely wholly on self-reported questionnaires that capture patients' perceptions of their symptoms and activities. These questionnaires are subjective, inherently vulnerable to recall bias, and do not capture the granularity of fluctuations over time. Several early adopters have integrated sensor-based digital health technology (DHT)-derived endpoints to measure physical function and activity in randomised controlled trials for conditions including Parkinson's disease, Duchenne's muscular dystrophy, chronic obstructive pulmonary disease, and heart failure. Despite these applications, there have been no sensor-based DHT-derived endpoints in clinical trials recruiting patients with inflammatory arthritis. Borrowing from case studies across medicine, we outline the opportunities and challenges in developing novel sensor-based DHT-derived endpoints that capture the symptoms and disease manifestations most relevant to patients with inflammatory arthritis.


Publication metadata

Author(s): McGagh D, Song K, Yuan H, Creagh AP, Fenton S, Ng W-F, Goldsack JC, Dixon WG, Doherty A, Coates LC

Publication type: Review

Publication status: Published

Journal: The Lancet Rheumatology

Year: 2024

Pages: ePub ahead of Print

Online publication date: 29/07/2024

Acceptance date: 02/04/2018

ISSN (electronic): 2665-9913

Publisher: Elsevier Ltd

URL: https://doi.org/10.1016/S2665-9913(24)00186-3

DOI: 10.1016/S2665-9913(24)00186-3


Share